论文部分内容阅读
AIM To describe our experience using a low-acceleratingdoseregimen (LADR) with pegylated interferon alpha-2a and ribavirin in treatment of hepatitis C virus (HCV)recurrence.METHODS: From 2003, a protocolized LADR strategywas employed to treat liver transp